Market Opportunity

Market Opportunity

Focusing on the Triple Aim of Heathcare

Chronic Wounds are a Silent Epidemic in Australia

Per year there is an estimated

48,000 venous leg ulcers (VLU) and 16,000 diabetic foot ulcers (DFU)

Blood flow measurement devices are imperative for

Diagnosing various clinical vascular conditions such as arterial occlusion, peripheral vascular diseases including diabetic micro and macro vascular complications. These devices also find their applications in skin testing, cerebral blood flow measurement, burn assessment and others. As per American Diabetes Association an estimated 1 out of every 3 people with diabetes is above 50 years of age. A rising geriatric population worldwide coupled with an accentuated demand for minimally invasive procedures has triggered the growth of this market.

A SEGMENTED MARKET

Blood flow measurement devices market has been segmented into Ankle Brachial Index (ABI) ultrasonic Doppler, laser Doppler and electromagnetic.

High cost capital items that require specialised training

There is limited availability of capital equipment and such devices are are typically only used in specialised clinics, in major towns and cities. There is a real need for a widely available, low cost blood flow monitoring device for that can be used by patients and assessed by clinicians.

HemoMedic is designed for this unmet market need and consequently addresses the “Triple Aim” – a focus of Healthcare Systems all around the world.